Akero Therapeutics (AKRO) Insider Trading & Ownership

→ Elon Musk: “This Could be Massive…a Multi Trillion-Dollar Company.” (From Paradigm Press) (Ad)

$23.46

+0.06 (+0.26%)

(As of 06/28/2024 ET)

Current Insider Ownership Percentage: 7.94%
Number Of Insiders Buying (Last 12 Months): 1
Amount Of Insider Buying (Last 12 Months): $6.24 M
Number Of Insiders Selling (Last 12 Months): 5
Amount Of Insider Selling (Last 12 Months): $9.23 M

Get AKRO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Akero Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AKRO Insider Buying and Selling by Quarter

Ad InvestorPlace

Where AI is REALLY Going Next

Buying Nvidia was a good idea – twenty years ago when I first recommended it (for up to 37,000% gains). But chipmakers are the FIRST GENERATION of AI. And just like the dot-com era… That’s NOT where the big money will be made.

Here’s what I’m recommending now (includes 2 stock tickers).

Akero Therapeutics Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
6/11/2024	Andrew Cheng	CEO	Sell	7,894	$22.64	$178,720.16
6/11/2024	Catriona Yale	Insider	Sell	2,825	$22.64	$63,958.00
6/11/2024	Jonathan Young	COO	Sell	2,516	$22.64	$56,962.24
6/11/2024	Patrick Lamy	VP	Sell	569	$22.64	$12,882.16
6/11/2024	William Richard White	CFO	Sell	2,831	$22.64	$64,093.84
6/3/2024	Jonathan Young	COO	Sell	5,000	$19.29	$96,450.00
I spent 44 years on Wall Street. If you knew what I know, you’d be terrified too. (Ad) The Most Important Presentation in America Right Now "Most people won't know what to do when their savings run out... Or when the stocks in their portfolios fall by half," says Wall Street icon Louis Navellier. "It's going to affect everything about our normal way of life: Our money, the value of our homes, our ability to retire." When it makes landfall, it's impact will be more violent and more severe than any financial crisis we've ever seen… Click here to see his official warning.
5/1/2024	Jonathan Young	COO	Sell	5,000	$20.15	$100,750.00
4/1/2024	Jonathan Young	COO	Sell	5,000	$24.38	$121,900.00
3/4/2024	Andrew Cheng	CEO	Sell	75,000	$32.87	$2,465,250.00
3/4/2024	Catriona Yale	Insider	Sell	20,646	$35.49	$732,726.54
12/27/2023	Jonathan Young	COO	Sell	5,414	$24.00	$129,936.00
12/14/2023	Andrew Cheng	CEO	Sell	1,628	$20.76	$33,797.28
12/14/2023	Catriona Yale	Insider	Sell	597	$20.76	$12,393.72
12/14/2023	Jonathan Young	COO	Sell	543	$20.76	$11,272.68
12/14/2023	William Richard White	CFO	Sell	611	$20.76	$12,684.36
12/11/2023	Andrew Cheng	CEO	Sell	7,405	$20.02	$148,248.10
12/8/2023	Andrew Cheng	CEO	Sell	12,873	$20.01	$257,588.73
12/8/2023	G. Walmsley Graham	Director	Buy	100,000	$19.83	$1,983,000.00
11/30/2023	G. Walmsley Graham	Director	Buy	50,000	$16.90	$845,000.00
11/17/2023	Jonathan Young	COO	Sell	30,000	$14.68	$440,400.00
10/2/2023	Andrew Cheng	CEO	Sell	25,000	$47.91	$1,197,750.00
10/2/2023	Jonathan Young	COO	Sell	490	$51.10	$25,039.00
9/21/2023	Catriona Yale	Insider	Sell	5,000	$48.07	$240,350.00
9/13/2023	Andrew Cheng	CEO	Sell	1,682	$50.34	$84,671.88
9/13/2023	Catriona Yale	Insider	Sell	617	$50.34	$31,059.78
9/13/2023	Jonathan Young	COO	Sell	562	$50.34	$28,291.08
9/13/2023	William Richard White	CFO	Sell	632	$50.34	$31,814.88
9/1/2023	Andrew Cheng	CEO	Sell	25,000	$49.77	$1,244,250.00
8/28/2023	Catriona Yale	Insider	Sell	5,745	$49.99	$287,192.55
8/8/2023	G. Walmsley Graham	Director	Buy	25,000	$42.06	$1,051,500.00
8/1/2023	G. Walmsley Graham	Director	Buy	25,000	$43.26	$1,081,500.00
7/28/2023	G. Walmsley Graham	Director	Buy	30,000	$42.69	$1,280,700.00
7/3/2023	Andrew Cheng	CEO	Sell	25,000	$44.88	$1,122,000.00

(Data available from 1/1/2013 forward)

AKRO Insider Trading Activity - Frequently Asked Questions

Who is on Akero Therapeutics's Insider Roster?: The list of insiders at Akero Therapeutics includes Andrew Cheng, Catriona Yale, G. Walmsley Graham, Jonathan Young, Patrick Lamy, Seth Loring Harrison, Skorpios Trust, Timothy Rolph, Tomas J. Heyman, and William Richard White. Learn more on insiders at AKRO.
What percentage of Akero Therapeutics stock is owned by insiders?: 7.94% of Akero Therapeutics stock is owned by insiders. Learn more on AKRO's insider holdings.
Which Akero Therapeutics insiders have been buying company stock?: The following insider purchased AKRO shares in the last 24 months: G. Walmsley Graham ($11,281,700.00).

How much insider buying is happening at Akero Therapeutics?: Insiders have purchased a total of 350,000 AKRO shares in the last 24 months for a total of $11,281,700.00 bought.
Which Akero Therapeutics insiders have been selling company stock?: The following insiders have sold AKRO shares in the last 24 months: Andrew Cheng ($16,570,899.23), Catriona Yale ($4,474,189.33), Jonathan Young ($2,698,877.36), Patrick Lamy ($12,882.16), Seth Loring Harrison ($3,482,566.52), Skorpios Trust ($71,166,000.00), Timothy Rolph ($7,374,976.73), Tomas J. Heyman ($1,421,420.00), and William Richard White ($3,009,340.28).
How much insider selling is happening at Akero Therapeutics?: Insiders have sold a total of 2,614,981 Akero Therapeutics shares in the last 24 months for a total of $110,211,151.61 sold.